Javascript must be enabled to continue!
GeneXpert-Detected Mycobacterium tuberculosis in Sudan: Insights into Rifampicin Resistance
View through CrossRef
Abstract
Background
: This study aimed to determine the prevalence of Tuberculosis (TB) and Rifampicin-resistant Tuberculosis (RR-TB) among Sudanese patients tested using the GeneXpert method.
Methods:
Data were extracted from the medical records of presumptive tuberculosis patients who attended the hospital from February to October 2025. Sputum samples from presumptive Tuberculosis patients were analyzed using the GeneXpert MTB/RIF assay to detect Mycobacterium tuberculosis and Rifampicin resistance.
Results
: A total of 153 sputum samples were analyzed. There were male (71.9%) and female (28.1%) participants. The majority of participants (41.8%) were aged 40-64 years, followed by those aged 25-39 years (33.3%). Younger participants aged 15-24years represented (12.4%). At the same time, only a small fraction were children aged 1-14 years (2%). Mycobacterium tuberculosis was detected in 29 cases (19.0%), and 81% were negative. Among the positive cases, moderate bacillary levels were most common (48.3%). Rifampicin resistance was detected in only one case (0.7%), with one additional inconclusive result; the remaining positive cases were sensitive (18.3%). A small number of participants reported previous TB Infection (4.6%) or HIV Infection (1.3%).
Chi-square analysis revealed no statistically significant relationship between age (p=0.454) and gender (p=0.228). In contrast, previous TB Infection(p<0.001), and HIV Status (p=0.018) showed a strong association with TB detection. No significant association between age, gender, previous TB infection, and rifampicin resistance (p>0.05)
Conclusions:
The findings reveal a high prevalence of tuberculosis and significant recurrence among presumptive cases, suggesting gaps in the treatment cascade. The low rate of rifampicin resistance is a cautiously optimistic, yet preliminary, finding, highlighting the need for strengthened surveillance and continuity of care in Sudan's conflict-affected setting.
Springer Science and Business Media LLC
Title: GeneXpert-Detected Mycobacterium tuberculosis in Sudan: Insights into Rifampicin Resistance
Description:
Abstract
Background
: This study aimed to determine the prevalence of Tuberculosis (TB) and Rifampicin-resistant Tuberculosis (RR-TB) among Sudanese patients tested using the GeneXpert method.
Methods:
Data were extracted from the medical records of presumptive tuberculosis patients who attended the hospital from February to October 2025.
Sputum samples from presumptive Tuberculosis patients were analyzed using the GeneXpert MTB/RIF assay to detect Mycobacterium tuberculosis and Rifampicin resistance.
Results
: A total of 153 sputum samples were analyzed.
There were male (71.
9%) and female (28.
1%) participants.
The majority of participants (41.
8%) were aged 40-64 years, followed by those aged 25-39 years (33.
3%).
Younger participants aged 15-24years represented (12.
4%).
At the same time, only a small fraction were children aged 1-14 years (2%).
Mycobacterium tuberculosis was detected in 29 cases (19.
0%), and 81% were negative.
Among the positive cases, moderate bacillary levels were most common (48.
3%).
Rifampicin resistance was detected in only one case (0.
7%), with one additional inconclusive result; the remaining positive cases were sensitive (18.
3%).
A small number of participants reported previous TB Infection (4.
6%) or HIV Infection (1.
3%).
Chi-square analysis revealed no statistically significant relationship between age (p=0.
454) and gender (p=0.
228).
In contrast, previous TB Infection(p<0.
001), and HIV Status (p=0.
018) showed a strong association with TB detection.
No significant association between age, gender, previous TB infection, and rifampicin resistance (p>0.
05)
Conclusions:
The findings reveal a high prevalence of tuberculosis and significant recurrence among presumptive cases, suggesting gaps in the treatment cascade.
The low rate of rifampicin resistance is a cautiously optimistic, yet preliminary, finding, highlighting the need for strengthened surveillance and continuity of care in Sudan's conflict-affected setting.
Related Results
Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study
Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study
Abstract
Background
Tuberculosis (TB) is a major public health concern in the developing countries. Moreover, the emergence of multidrug-resistant t...
Trends of Mycobacterium Tuberculosis and rifampicin resistance in Adigrat General Hospital, Eastern Zone of Tigrai, North Ethiopia
Trends of Mycobacterium Tuberculosis and rifampicin resistance in Adigrat General Hospital, Eastern Zone of Tigrai, North Ethiopia
Abstract
Background: Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. The global emergence of mono- or multidrug-resistant tuber...
Trends of Mycobacterium Tuberculosis and Rifampicin resistance in Adigrat General Hospital, Eastern zone, Tigray Region, Northern Ethiopia
Trends of Mycobacterium Tuberculosis and Rifampicin resistance in Adigrat General Hospital, Eastern zone, Tigray Region, Northern Ethiopia
Abstract
Background: Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. The global emergence of mono- or multidrug-resistant tuber...
Trends of Mycobacterium Tuberculosis and rifampicin Resistance in Adigrat General Hospital, Eastern zone of Tigrai, North Ethiopia
Trends of Mycobacterium Tuberculosis and rifampicin Resistance in Adigrat General Hospital, Eastern zone of Tigrai, North Ethiopia
Abstract
Background: Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. The global emergence of mono- or multidrug-resistant tuber...
DIAGNÓSTICO MOLECULAR DE TUBERCULOSIS Y EVALUACIÓN DEL GEN RPOB UTILIZANDO GENEXPERT MTB/RIF Y GENEXPERT MTB/RIF ULTRA
DIAGNÓSTICO MOLECULAR DE TUBERCULOSIS Y EVALUACIÓN DEL GEN RPOB UTILIZANDO GENEXPERT MTB/RIF Y GENEXPERT MTB/RIF ULTRA
Meta: Identificación y análisis de las mutaciones de sondas del gen rpoB de Mycobacterium tuberculosis asociadas a resistencia a rifampicina utilizando GeneXpert MTB/RIF y GeneXper...
Trends in Mycobacterium Tuberculosis and prevalence of Rifampicin Resistance in Eastern zone, Tigray Region, Northern Ethiopia
Trends in Mycobacterium Tuberculosis and prevalence of Rifampicin Resistance in Eastern zone, Tigray Region, Northern Ethiopia
Abstract
Background Tuberculosis (TB) is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. The emergence of Mono or multidrug-resistant tub...
Magnitude of tuberculosis lymphadenitis, risk factors, and rifampicin resistance at Adama city, Ethiopia: a cross-sectional study
Magnitude of tuberculosis lymphadenitis, risk factors, and rifampicin resistance at Adama city, Ethiopia: a cross-sectional study
AbstractMycobacterium tuberculosis complex has an impact on public health and is responsible for over one million deaths per year. Substantial numbers of people infected with M. tu...
Comparison of GeneXpert and line probe assay for the detection of Mycobacterium tuberculosis in direct sputum samples
Comparison of GeneXpert and line probe assay for the detection of Mycobacterium tuberculosis in direct sputum samples
Tuberculosis (TB) remains a major global health issue, particularly in low-and- middle-income countries (LMICs) like Indonesia. Diagnostic methods for TB and multidrug-resistant TB...

